In this issue:
Reversal of cirrhosis in HBV
Achieving SVR in HCV protects against HCC
Better HCC surveillance strategies needed
HBeAg levels and response to PEG-IFN
IL28B genotype: limited impact on telaprevir response
Antivirals reduce reactivation risk with hepatectomy
HCV sexual transmission rare in stable heterosexual couples
Anaemia during PEG-IFN/RBV + boceprevir
PEG-IFN/RBV in paediatric HCV populations
IFN-induced depression in CHC
Refined stopping rules during PEG-IFN/RBV + BOC in HCV
Please login below to download this issue (PDF)